Objective quantification of small fiber neuropathy in patients with human immunodeficiency virus (HIV)-associated sensory neuropathy (HIV-SN) is difficult but needed for diagnosis and monitoring. In vivo corneal confocal microscopy (IVCCM) can quantify small fiber damage. Results from patients with HIV were compared with the results of the age-and sex-matched healthy control participants (n = 20). All participants were classified into 3 groups: controls, patients with HIV but without SN, and patients with HIV-SN.
H uman immunodeficiency virus-associated sensory neuropathy (HIV-SN) is one of the most frequent neurologic consequences of HIV infection and its treatment. 1 Patients with HIV-SN present with pain and paraesthesia, and their quality of life and ability to work are substantially affected. 2 Small fiber neuropathy can be accurately assessed by quantifying intraepidermal nerve fiber density but is invasive and does not easily facilitate longitudinal studies. 3 In vivo corneal confocal microscopy (IVCCM) is a rapid, noninvasive ophthalmic imaging technique that can quantify small nerve fiber damage in diabetic neuropathy, 4 hereditary Charcot-Marie-Tooth type 1A, 5 chemotherapy-induced peripheral neuropathy, 6 chronic inflammatory demyelinating polyneuropathy, 7 and amyloid neuropathy. 8 In a nonhuman primate model of HIV-SN, animals with the most severe disease showed a decrease in corneal nerve fiber density, 9 and IVCCM has demonstrated a reduction in corneal nerve fiber length in HIV-positive patients. 10 Epidermal
Langerhans cell (LC) density is reduced in patients with HIV or AIDS, 11 but in vivo assessment of corneal LC density has not been reported in HIV. This study undertook IVCCM to quantify corneal nerve fiber structure and LC density in patients with HIV.
Methods
Study participants had a diagnosis of HIV, and the exclusion criteria included pregnancy, peripheral vascular disease, severe coincident psychiatric diagnosis, other causes of peripheral neuropathy, nystagmus, or corneal surgery. Patients were recruited from adult outpatient clinics at Chelsea and Westminster Hospital NHS Foundation Trust in the United Kingdom. Images from age-and sex-matched healthy control participants (volunteers) were collected using the same image acquisition protocol as that used for the patient groups. 4 The study was conducted from July 24, 2015, to September 17, 2015. Image analysis was performed from April 7, 2016 , to April 18, 2016. Ethical approval for this study was granted by the National Ethics Research Service. This study was part of the EuroPain project (http://imieuropain.org) and was conducted in accordance with the Declaration of Helsinki. 12 All patients gave written informed consent to take part in the study.
Classification
All participants were classified into 3 groups: controls, patients with HIV but without HIV-SN, and patients with HIV-SN. (The presence of 1 sign and at least 1 symptom from the validated Clinical HIV-Associated Neuropathy Assessment Tool indicated neuropathy.
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) Patients with HIV underwent a structured clinical examination and completed the Douleur Neuropathique 4 interview (DN4-i; the score range was 0-7, and a DN4-i score higher than 3 was classified as painful neuropathy) as well as the Brief Pain Inventory (the severity range was 0-10 [0.0-7.0 for our patient cohort] with a pain interference scale of 0-10 [1.29-8.57 for our patient cohort]).
Image Acquisition and Quantification
Participants underwent IVCCM at Moorfields Eye Hospital NHS Foundation Trust in London, England, and IVCCM images were analyzed at Weill Cornell Medicine-Qatar in Ar-Rayyan, Qatar. 4 Images were acquired using a corneal confocal microscope (Heidelberg Retinal Tomography and Rostock Corneal Module; Heidelberg Engineering). Six images from the right and left eyes were selected for analysis and manually quantified by a single experienced examiner (I.N.P.) using CCMetrics software (M. A. Dabbah, University of Manchester). Corneal nerve fiber density (number per square millimeter), corneal nerve branch density (number per square millimeter), corneal nerve fiber length (in millimeters per square millimeter), corneal nerve fiber tortuosity, and corneal LC density (in cells per square millimeter) were quantified. 4 Patients did not undergo any assessment of corneal sensation.
Statistical Analysis
A power calculation using SigmaPlot, version 10.0 (Systat) of data from patients with diabetic polyneuropathy revealed a sample size of at least 6 participants per group to identify a difference in corneal nerve fiber length (mean Statistical analysis was performed using SPSS, version 22.0 (IBM). Data are presented as mean (SD) or median (interquartile range [IQR] ). Corneal nerve measures and corneal LC density in patients with HIV were compared with controls using the Wilcoxon rank sum test. The control and HIV groups (HIV without SN, HIV-SN) were compared using the Kruskal-Wallis test for continuous nonparametric data (with post hoc testing for pairwise comparisons). Median differences are reported using a Hodges-Lehmann estimate; because nonparametric data rely on ranks, exact 95% CIs were not always possible (exact CIs stated).
To reduce the chance of a type I error, a false detection rate correction was made to the P value using the Benjamini-Hochberg method. Spearman rank correlation was used between corneal nerve fiber measures and symptom severity scores.
Results
Twenty male patients with HIV were matched by age and sex to 20 healthy controls (Table) . All 40 participants were male,
Key Points
Question Can in vivo corneal confocal microscopy be used to assess changes in corneal nerve fiber structure and Langerhans cell density in patients with human immunodeficiency virus (HIV)-associated sensory neuropathy?
Findings In this cohort study of 20 patients with HIV, a decrease in corneal nerve fiber density and an increase in corneal nerve tortuosity were observed in patients with HIV-associated sensory neuropathy when compared with patients without neuropathy, with no change in Langerhans cell density.
Meaning In vivo corneal confocal microscopy is a noninvasive ophthalmic imaging technique that could aid in the diagnosis and longitudinal monitoring of patients with HIV-associated sensory neuropathy. (Figure 1 and Figure 2 and eTables 1 and 2 in the Supplement).
Adjustment for Covariates
Using corneal measures as dependent factors and group (control, HIV without SN, and HIV-SN) as an independent variable, we found no significant correlation between corneal measures and covariates of age and duration of HIV infection.
Correlations
There was a significant correlation between tortuosity coefficient with Brief Pain Inventory severity (r = 0.628; P = .003) and interference scores (r = 0.650; P = .002). There was no correlation between corneal nerve fiber measures and duration of HIV, age, duration of treatment with antiretroviral medication, most recent or nadir CD4 count, or peak viral load.
Discussion
Neuropathy is a frequent complication of HIV infection and its treatment, affecting 32% to 67% of patients in 1 study. 1 We show that IVCCM can quantify small nerve fiber damage in patients with HIV, particularly patients with HIV-SN. Corneal nerve fiber density was reduced in patients with HIV without neuropathy, indicating subclinical small nerve fiber damage. Patients with HIV-SN demonstrated reduced corneal nerve fiber density and increased tortuosity with more branching. This reduction in corneal nerve fiber measures replicates the findings in simian immunodeficiency virus-infected macaques 8 and in patients with HIV, 9 diabetic neuropathy, 4 CharcotMarie-Tooth type 1A, 5 chemotherapy-induced peripheral neuropathy, 6 chronic inflammatory demyelinating polyneuropathy, 7 and amyloid neuropathy. 8 Langerhans cells modulate the transmission of HIV 11 and may be increased because of anterior segment pathologic changes causing corneal nerve damage. 15 Our study showing a progressive reduction in corneal nerve fiber density and an increase in corneal nerve tortuosity.
Research Brief Report
demonstrated no change in corneal LC density in patients with HIV, and a recent study of patients with stable CD4 counts showed a low incidence of anterior segment abnormality. 16 
Limitations
In healthy controls, advancing age correlates with decreasing corneal nerve fiber density and corneal nerve fiber length and an increasing tortuosity coefficient. 17 Although patients with HIV-SN were slightly older than those without HIV-SN, no significant effect of age was demonstrated. Future studies, using esthesiometry, should relate corneal nerve fiber loss with corneal sensation functional loss given that intraepidermal nerve fiber density correlates with quantitative sensory testing in HIV. IVCCM (in vivo corneal confocal microscopy), CNFL (corneal nerve fiber length), CNFD (corneal nerve fiber density), CNBD (corneal nerve fiber branch density), TC (tortuosity coefficient), LCD (Langerhans cell density). Pairwise comparison after Benjamini Hochberg correction showed significant differences between HIV patients with (HIV-SN) and without (HIV-no SN) sensory neuropathy for TC (P=0.01). CNFD neared significance (P=0.032) between those with and without sensory neuropathy. Median difference reported as Hodges-Lehmann estimate, all confidence intervals are 95%+/-0.99%
